Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/48248
Título: | Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides | Autores/as: | Quintana-Espinoza, Patricia García-Luis, Jonay Amesty, Ángel Martín Rodríguez, Patricia Lorenzo-Castrillejo, Isabel Ravelo, Angel G. Fernández Pérez, Leandro Fco Machín, Félix Estévez-Braun, Ana |
Clasificación UNESCO: | 32 Ciencias médicas 2302 Bioquímica |
Palabras clave: | Topoisomerase-Ii Homologous Recombination Biological-Activity Anticancer Agents Amonafide, et al. |
Fecha de publicación: | 2013 | Publicación seriada: | Bioorganic and Medicinal Chemistry | Resumen: | A series of arylnaphthalimides were designed and synthesized to overcome the dose-limiting cytotoxicity of N-acetylated metabolites arising from amonafide, the prototypical antitumour naphthalimide whose biomedical properties have been related to its ability to intercalate the DNA and poison the enzyme Topoisomerase II. Thus, these arylnaphthalimides were first evaluated for their antiproliferative activity against two tumour cell lines and for their antitopoisomerase II in vitro activities, together with their ability to intercalate the DNA in vitro and also through docking modelization. Then, the well-known DNA damage response in Saccharomyces cerevisiae was employed to critically evaluate whether these novel compounds can damage the DNA in vivo. By performing all these assays we conclude that the 5-arylsubstituted naphthalimides not only keep but also improve amonafide's biological activities. | URI: | http://hdl.handle.net/10553/48248 | ISSN: | 0968-0896 | DOI: | 10.1016/j.bmc.2013.08.039 | Fuente: | Bioorganic & Medicinal Chemistry[ISSN 0968-0896],v. 21 (21), p. 6484-6495 |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.